Inventor
REW YOSUP
US30 patents
⚠️ This page may combine multiple inventors who share the name “REW YOSUP”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ORIC PHARMACEUTICALS INC
15 patentsUS11028120B2Jun 8, 2021
CD73 inhibitors
ORIC PHARMACEUTICALS INC10 citations93
US12018043B2Jun 25, 2024
CD73 inhibitors
ORIC PHARMACEUTICALS INC6 citations85
US11325938B2May 10, 2022
CD73 inhibitors
ORIC PHARMACEUTICALS INC9 citations85
US11530236B2Dec 20, 2022
CD73 inhibitors
ORIC PHARMACEUTICALS INC4 citations83
US11130778B2Sep 28, 2021
CD73 inhibitors
ORIC PHARMACEUTICALS INC8 citations83
US10472387B2Nov 12, 2019
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC2 citations73
US12577272B2Mar 17, 2026
CD73 inhibitors
ORIC PHARMACEUTICALS INC0 citations62
US12454544B2Oct 28, 2025
CD73 inhibitors
ORIC PHARMACEUTICALS INC0 citations62
US11807658B2Nov 7, 2023
CD73 inhibitors
ORIC PHARMACEUTICALS INC1 citations62
US11124537B2Sep 21, 2021
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC1 citations61
US12544391B2Feb 10, 2026
CD73 inhibitors
ORIC PHARMACEUTICALS INC0 citations51
US11208432B2Dec 28, 2021
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC0 citations51
US11110103B2Sep 7, 2021
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC0 citations51
US10836789B2Nov 17, 2020
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC0 citations51
US10723759B2Jul 28, 2020
Inhibitors of glucocorticoid receptor
ORIC PHARMACEUTICALS INC0 citations51
AMGEN INC
11 patentsUS8952036B2Feb 10, 2015
Benzoic acid derivative MDM2 inhibitor for the treatment of cancer
AMGEN INC15 citations84
US9593129B2Mar 14, 2017
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
AMGEN INC5 citations83
US9296736B2Mar 29, 2016
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
AMGEN INC7 citations83
US9376425B2Jun 28, 2016
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
AMGEN INC12 citations82
US11306107B2Apr 19, 2022
Compounds that inhibit MCL-1 protein
AMGEN INC2 citations71
US7402704B2Jul 22, 2008
Arylsulfones and uses related thereto
AMGEN INC3 citations62
US7605289B2Oct 20, 2009
Benzamide derivatives and uses related thereto
AMGEN INC4 citations60
US7659287B2Feb 9, 2010
Benzamide derivatives and uses related thereto
AMGEN INC1 citations52
US7754890B2Jul 13, 2010
Arylsulfones and uses related thereto
AMGEN INC0 citations51
US11407721B2Aug 9, 2022
CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
AMGEN INC0 citations50
US11274105B2Mar 15, 2022
Alpha-hydroxy phenylacetic acid pharmacophore or bioisostere Mcl-1 protein antagonists
AMGEN INC0 citations48